Effect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferens
S. Karunanithi et Na. Lavidis, Effect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferens, BR J PHARM, 132(2), 2001, pp. 403-410
1 The effect of chronic morphine treatment (CMT) on sympathetic innervation
of the mouse vas deferens and on alpha (2)-adrenoceptor mediated autoinhib
ition has been examined using intracellular recording of excitatory junctio
n potentials (EJPs) and histochemistry.
2 In chronically saline treated (CST) preparations. morphine (1 muM) and th
e alpha (2)-adrenoceptor agonist (clonidine, 1 muM) decreased the mean ampl
itude of EJPs evoked with 0.03 Hz stimulation by 81+/-8% (n=16) and 92+/-6%
(n=7) respectively. In CMT preparations, morphine (1 muM) and clonidine (1
muM) decreased mean EJP amplitude by 68+/-8% (n = 7) and 79+/-8% (n = 7) r
espectively.
3 When stimulating the sympathetic axons at 0.03 Hz. the mean EJP amplitude
recorded from smooth muscles acutely withdrawn from CMT was four times gre
ater than for CST smooth muscles (40.7+/-3.8 mV, n = 7 compared with 9.9+/-
0.3 mV, n = 7).
4 Part of the increase in mean EJP amplitude following CMT was produced by
a 31% increase in the density of sympathetic axons and varicosities innerva
ting the smooth muscle.
5 Results from the present study indicate that the effectiveness of alpha (
2)-adrenocrptor mediated autoinhibition is only slightly reduced in CMT pre
parations. Most of the cross tolerance which develops between morphine, clo
nidine and alpha (2)-adrenoceptor mediated autoinhibition occurs as a conse
quence of increased efficacy of neuromuscular transmission which is produce
d by an increase in the probability of transmitter release and an increase
in the density of sympathetic innervation.